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Abstract
Background: Recurrent/moderate (R/M) hypoglycemia is common in type 1 diabetes. Although mild or moderate
hypoglycemia is not life-threatening, if recurrent, it may cause cognitive impairment. In the present study, we
sought to determine whether R/M hypoglycemia leads to neuronal death, dendritic injury, or cognitive impairment.
Methods: The experiments were conducted in normal and in diabetic rats. Rats were subjected to moderate
hypoglycemia by insulin without anesthesia. Oxidative stress was evaluated by 4-Hydroxy-2-nonenal
immunostaining and neuronal death was determined by Fluoro-Jade B staining 7 days after R/M hypoglycemia. To
test whether oxidative injury caused by NADPH oxidase activation, an NADPH oxidase inhibitor, apocynin, was used.
Cognitive function was assessed by Barnes maze and open field tests at 6 weeks after R/M hypoglycemia.
Results: The present study found that oxidative injury was detected in the dendritic area of the hippocampus after
R/M hypoglycemia. Sparse neuronal death was found in the cortex, but no neuronal death was detected in the
hippocampus. Significant cognitive impairment and thinning of the CA1 dendritic region was detected 6 weeks
after hypoglycemia. Oxidative injury, cognitive impairment, and hippocampal thinning after R/M hypoglycemia
were more severe in diabetic rats than in non-diabetic rats. Oxidative damage in the hippocampal CA1 dendritic
area and microglial activation were reduced by the NADPH oxidase inhibitor, apocynin.
Conclusion: The present study suggests that oxidative injury of the hippocampal CA1 dendritic region by R/M
hypoglycemia is associated with chronic cognitive impairment in diabetic patients. The present study further
suggests that NADPH oxidase inhibition may prevent R/M hypoglycemia-induced hippocampal dendritic injury.
Keywords: Recurrent/moderate hypoglycemia, Dendrite, Superoxide, Lipid peroxidation, Neuron death, Microglial
activation, NADPH oxidase, Apocynin
Introduction
Recurrent/moderate (R/M) hypoglycemia, which is more
common than severe hypoglycemia in type 1 diabetes
patients (frequency is 0.1 to 0.3 episode/patient per day),
is usually corrected by patients themselves or unrealized.
Therefore, these episodes may be easily forgotten and re-
main untreated [1-4]. Although moderate hypoglycemia
is not life-threatening, if recurrent, it may have serious
clinical implications. Poor academic performance in dia-
betic children and memory impairment in adults with
diabetes are viewed as areas of increasing public concern.
These problems are typically thought to result from
hypoglycemic attacks, which occur more frequently dur-
ing intensive insulin therapy [5-8].
The normal range for human blood glucose concentra-
tion is 3.9 to 7.1 mM (1 mM=approximately 18 mg/dl),
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and hypoglycemia is broadly defined as glucose concen-
trations that fall below this range. Reducing food intake
does not reduce blood glucose levels below 2.8 mM, even
with prolonged fasting [9], however, reductions below
1 mM can be induced by the administration of insulin or
drugs such as sulfonylurea derivatives. Hypoglycemic
brain injury occurs most frequently in diabetic patients
attempting tight glucose control [10,11], and conse-
quently the risk of hypoglycemic brain injury is the major
factor limiting tight glucose control. Although there is no
strict definition, hypoglycemia is generally classified as
mild (3.2 to 3.6 mM), moderate (2.3 to 3.2 mM) and se-
vere (<2 mM) hypoglycemia in humans [12]. While most
diabetic patients experience mild to severe hypoglycemia
at times, very few experience severe hypoglycemia to a
degree that results in coma.
Studies using mice and rats indicate that widespread
neuronal death does not occur unless blood glucose con-
centration falls below 1 mM and cortical electroencepha-
lographic (EEG) activity remains isoelectric (silent) for at
least 10 min. However, it is still possible to detect
scattered neuronal death, even at early stages of electro-
cerebral silence or sustained blood glucose concentra-
tions just in excess of 1 mM [13-16]. Case studies suggest
that a similar degree of hypoglycemia is required to in-
duce brain injury in humans, although this may vary in
children, susceptible individuals with repeated hypogly-
cemia and the presence of co-morbid factors [17-22].
The main risk factors for cognitive impairment in dia-
betes are considered to be age, duration of diabetes, and
coexistent microvascular and macrovascular complica-
tions [23]. Diabetes should be treated as a risk factor for
cognitive impairment, and likewise, cognitive impair-
ment is associated with poorer ability in diabetes self-
care and decreased adherence to anti-diabetic treatment,
setting the stage for a potential vicious cycle of decline
in quality of life and disease management.
Children with type 1 diabetes who suffer recurrent and
severe hypoglycemia while younger than 5 years old have
impaired mental abilities later in life [6,24]. The combin-
ation of an early onset of diabetes and recurrent epi-
sodes of hypoglycemia appears to be associated with
reduced attention and spatial memory in adolescence
[24-27]. Within the diabetic group, verbal intelligence
was reduced with increased exposure to hyperglycemia,
but not to hypoglycemia. In contrast, spatial intelligence
and delayed recall were reduced only with repeated
hypoglycemia, particularly when hypoglycemic episodes
occurred before the age of 5 years [28].
Recurrent episodes of mild/moderate hypoglycemia are
associated with a decreased perception of the
hypoglycemic state and blunted secretion of counter-
regulatory hormones, phenomena termed ‘hypoglycemia
unawareness’ and ‘hypoglycemia-associated autonomic
failure’ (HAAF), respectively [29-31]. In diabetic patients,
even mild to moderate hypoglycemia may produce a sig-
nificant increase in low-frequency EEG activity [32] and
impair cognitive function [33]. Several studies have
sought to determine the cognitive impact of recurrent
hypoglycemia, but results from clinical studies have been
mixed and the question of whether recurrent exposure to
severe hypoglycemia promotes long-term cognitive dys-
function is unresolved.
There have been several studies performed to deter-
mine whether neuronal death is induced after moderate
hypoglycemia, which is defined as low blood glucose
levels (below 2 mM blood glucose for more than 2 h)
without the presence of isoelectric EEG (iso-EEG).
These studies concluded that moderate hypoglycemia
induced scattered neuronal death in the cerebral cortex
layer 2–3 [34], but not in the hippocampus. Yamada et al.
also found that moderate hypoglycemia led to no hippo-
campal neuronal death, however, they did observe sig-
nificantly deteriorated synaptic plasticity, demonstrated
by an inability to induce long term potentiation (LTP) at
CA1 synapses [35]. Thus, we speculated that repetitive
episodes of moderate hypoglycemia might lead to synap-
tic injury in the hippocampus in the absence of apparent
neuronal somatic injuries in the hippocampus, and con-
sequently, the development of cognitive impairments.
To date, several hypoglycemia experiments have been
performed with normal (non-diabetic) adult rodents;
therefore the clinical implication of these studies is not
readily apparent since moderate hypoglycemia com-
monly occurs in juvenile type 1 diabetes patients. There-
fore, the present study was conducted in 1-month-old
young rats that were rendered diabetic by streptozotocin
(STZ) injection, mimicking juvenile type 1 diabetes.
To test our hypothesis, the present study has
addressed five questions. First, does a single episode of
moderate hypoglycemia (without anesthesia and without
iso-EEG) cause dendritic oxidative injury in the hippo-
campus? Second, if not, do repeated episodes of moder-
ate hypoglycemia cause dendritic oxidative injury in the
hippocampus? If so, third, do repeated episodes of mod-
erate hypoglycemia cause cognitive impairment at a later
time point? Fourth, is there a difference in cognitive
function between non-diabetic and diabetic rats, with re-
spect to the synaptic effects of R/M hypoglycemia? Fifth,
is oxidative injury or microglial activation after R/M
hypoglycemia mediated by NADPH oxidase?
Materials and methods
The surgical and animal care procedures were in accord-
ance with the guidelines of the Institutional Animal Care
and Use Committee of the San Francisco Veterans
Affairs Medical Center (animal welfare assurance num-
ber A3476-01) and of the Hallym University (Hallym
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2011–44). This manuscript was written up in accordance
with the ARRIVE (Animal Research: Reporting In Vivo
Experiments) guidelines [36].
Type 1 diabetes rat
For the type 1 diabetes model, rats received repeated
intraperitoneal injections of streptozotocin (STZ). One-
month-old male Sprague Dawley rats were injected with
50 mg/kg STZ (twice; second injection occurred 24 h
after the first injection, i.p.). Rats displaying fasting
blood glucose levels higher than 200 mg/dl 7 days after
the first injection were used in this experiment. All rats
injected with STZ showed typical symptoms of diabetes
such as polydipsia, polyphagia, and polyuria. Although
the STZ-induced diabetes mellitus (DM) model has cer-
tain caveats, this model offers a very effective technique
that can be used in most rodents [37]. Fasting blood glu-
cose levels in STZ-treated rats were left uncorrected and
fell in the range of 10 to 20 mM.
R/M hypoglycemia
One week after STZ injection, R/M hypoglycemia was
induced without anesthesia. After overnight fasting, rats
were given an insulin injection (5 U/kg, i.p.) to induce
moderate hypoglycemia, as previously described with
minor modification [38]. After insulin injection, blood
glucose was measured from the tail vein using ACCU-
CHEK glucometer (Roche, Indianapolis, IN, USA) at 30-
min intervals. Blood glucose levels between 1 and 2 mM
were maintained for 1 h. Blood glucose level was
increased by intraperitoneal injection of glucose (25%/
1 mL/bolus) 1 h after moderate hypoglycemia (Table 1).
In the present study we defined ‘moderate hypoglycemia’
as sustained (1 h) blood glucose concentrations between
1 to 2 mM without coma. This process was repeated for
5 consecutive days (Additional file 1: Figure S1). Rats
were randomly assigned to two groups; one for studying
the role of oxidative stress and the other group for cogni-
tive testing 6 weeks post-insult. To test whether NADPH
oxidase activation is involved in R/M hypoglycemia-
induced oxidative injury in hippocampal dendrites, the
NADPH oxidase assembly inhibitor, apocynin, was
injected intraperitoneally (15 mg/kg, Sigma, St Louis,
MO, USA) immediately after R/M hypoglycemia. Since
half-life of apocynin is about 1 h [39], we believe that
apocynin may inhibit glucose reperfusion-induced
NADPH oxidase activation for 2 to 3 h. Apocynin was
dissolved in 1% DMSO (dimethylsulphoxide) and control
rats for these studies received equal volumes of vehicle
alone. This process was repeated for 5 consecutive days
(Additional file 1: Figure S1).
Acute/severe (A/S) hypoglycemia
As a means of comparison with R/M hypoglycemia, A/S
hypoglycemia with diabetic rats was also performed in
the present study. Insulin-induced A/S hypoglycemia was
induced in rats as previous described, with the period of
severe hypoglycemia defined here as the interval during
which the EEG exhibited an isoelectric state for 30 min
[13,15]. Severe hypoglycemia was induced by intraperito-
neal injection of 30 U/kg of regular insulin (Novolin-R,
Novo Nordisk, Clayton, NC, USA) (Additional file 2:
Figure S2).
Evaluation of neuron degeneration
Neuronal death after R/M or A/S hypoglycemia was eval-
uated after a 7-day survival period. Rats were intracar-
dially perfused with 0.9% saline followed by 4%
paraformaldehyde (PFA). The brains were post-fixed with
4% PFA for 24 h and then incubated with 20% sucrose
for cryoprotection. For H&E staining, coronal 25 μm sec-
tions were conventionally stained [40]. Brain sections
were also prepared for the Fluoro-Jade B staining (FJB)
[15,41]. Degenerating cells were detected with 450 to
490 nm excitation and a 515 nm emission filter. Five cor-
onal sections were collected from each animal by starting
4.0 mm posterior to Bregma, and collecting every third
section until five sections were in hand. These sections
were then coded and given to a blinded experimenter
who counted the number of degenerating neurons in the
hippocampal CA1.
Evaluation of oxidative stress
Oxidative injury was estimated by evaluating levels of
the lipid peroxidation product, 4HNE (4-hydroxy-2-
nonenal). Immunostaining with microtubule-associated
protein 2 (MAP2; Millipore Co, Billerica, MA, USA) and
4HNE (Alpha Diagnostic Intl. Inc., San Antonio, TX,
USA) antibodies was performed as described previously
[42]. Three sections were analyzed from each brain,
taken at 80 μm intervals to span the hippocampus.
4HNE signal intensity was expressed as the ratio of the
mean fluorescence in SR of hippocampal CA1 to fluor-
escence in the lateral ventricles.
Table 1 Change in mean arterial blood glucose levels
before insulin injection, during moderate hypoglycemia
and after glucose reperfusion in diabetic and









4.72 ± 0.27 1.46 ± 0.04 5.61 ± 0.25
Diabetic
rats (n= 7)
16.43 ± 0.81 1.48 ± 0.10 17.31 ± 0.77
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Immunohistochemistry
For evaluation of dendritic damage, the sections were
immunostained with a rabbit antibody to rat MAP2
(Millipore Co, Billerica, MA, USA) at a 1:250 dilution.
For evaluation of microglial activation, the sections were
immunostained with a mouse antibody to rat CD11b
(Serotec, Raleigh, NC, USA) at a 1:200 dilution. Microglia
activation was evaluated by an observer blinded to experi-
mental conditions. Three sections from each animal were
evaluated for scoring. Microglia activation criteria were
depending on number of CD11b immunoreactive cells
and their morphology as published previously [43].
Behavioral assessments
Rats were handled for 5 min each per day and accli-
mated in the behavioral test room for 1 week prior to
the start of behavior testing. Six weeks following the
sham hypoglycemia or R/M hypoglycemia, rats were
first tested in the novel open field test to evaluate the
effects of diabetes and recurrent hypoglycemia on loco-
motor activity and exploratory behavior. In the open
field test, rats were placed in a brightly lit, square Plexi-
glas enclosure (40 x 40 inches), surrounded by
automated infrared photocells interfaced with a com-
puter (Hamilton & Kinder, San Diego, CA, USA) to rec-
ord the data. On each of 3 consecutive days, open field
activity was recorded for 10 min after an initial 1-min
adaptation period. For analysis of the exploratory behav-
ior, the arena was divided on a zone map consisting of
a center region (15 × 15 inches), four corner regions of
7.5 × 7.5 inches each, and a peripheral region (the
remaining area).
Subjects then underwent testing in the Barnes maze
test to evaluate spatial learning and memory [44]. Rats
from each treatment group were randomly assigned to
locate the escape tunnel from one of the three predeter-
mined locations to rule out spatial preference. Moder-
ately noxious stimuli, blowing fans and 500 LUX of
bright light, were used to increase the incentive in find-
ing the escape tunnel. Noldus EthoVision video tracking
system (Noldus, Leesburg, VA, USA) was used to record
and analyze the data. Rats were trained to locate the es-
cape tunnel in two successive daily sessions for 5 days
(three trials per session, 3 min per trial) with a 1-h
intersession interval from different counterbalanced
starting positions.
Figure 1 Neuronal death in the cerebral cortex and hippocampus after severe or moderate hypoglycemia in diabetic rats. (A) In sham
hypoglycemia-operated rats, neuronal death (FJB (+) neurons) was not detected in diabetic rats. In both diabetic and non-diabetic rats,
recurrent/moderate (R/M) hypoglycemia shows only occasional neuronal death in the cerebral cortex while acute/severe (A/S) hypoglycemia
shows widespread neuronal death in the superficial layer of cortex at 7 days after hypoglycemia. Bar = 100 μm. (B) Bar graph represents counted
degenerating neurons in the cerebral cortex. Data are mean+ s.e.m.; n= 5 in R/M hypoglycemia, n= 7 in A/S hypoglycemia * P< 0.05.
(C) R/M hypoglycemia shows no neuronal death (FJB (+) neurons) in the hippocampal CA1 and DG cell layer while severe hypoglycemia shows
substantial neuron death in the hippocampus at seven days after hypoglycemia. Bar = 100 μm. (D) Light microscopic images represent
hematoxylin & eosin (H&E) stained hippocampus from CA1 and DG cell layer. R/M hypoglycemia shows no neuronal death (eosinophilic) in the
hippocampal CA1 and DG cell layer while severe hypoglycemia shows substantial neuronal death in the hippocampus at seven days after
hypoglycemia. Bar = 100 μm.
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Statistical analysis
Data are expressed as means ± s.e.m. and assessed by
one-way ANOVA followed by either the Tukey-Kramer
test for multiple comparisons between groups or the
Dunnett’s test for comparisons of multiple groups
against a control group with Statview 5.0.1 software
(SAS Institute Inc., Cary, NC, USA). Behavioral data
were compared using two-way repeated measure
ANOVA (RANOVAs) followed by post hoc pairwise
comparisons using the Bonferroni test when appropriate.
Values of P< 0.05 were considered as significant.
Results
A/S hypoglycemia induces cortical and hippocampal
neuronal death in diabetic rats
Before initiating the R/M hypoglycemia experiments,
diabetic rats were subjected to A/S hypoglycemia to test
whether STZ-injected diabetic rats also have similar pat-
terns of neuronal injury as seen in previous studies using
non-diabetic rats (Figure 1). We found that, in the cere-
bral cortex, A/S hypoglycemia produced about twice as
much neuron death in diabetic rats as in non-diabetic
rats, compared to other historical controls [13,45] and
our previous study [15,42]. However, in the hippocam-
pus, diabetic and non-diabetic rats showed a similar de-
gree of neuronal death after A/S hypoglycemia. This
result is very similar to that reported by Bree et al. [46].
R/M hypoglycemia produces infrequent, sparse neuronal
death in the cerebral cortex
Neuronal death was evaluated in the cerebral cortex of
STZ-induced diabetic rats after R/M hypoglycemia
(Figure 1A and B). Neuronal injury evaluated by FJB
staining at 7 days after R/M hypoglycemia showed infre-
quent, sparse neuronal death in the parietal region of
cerebral cortex. Only three out of five diabetic rats
exhibited FJB(+) cells in the cerebral cortex.
R/M hypoglycemia does not produce neuronal death in
the hippocampus
Neuronal injury evaluated by H&E or FJB staining at 7 days
after A/S hypoglycemia showed widespread neuronal death
in the hippocampus of type-1 diabetes mellitus model rats.
However, R/M hypoglycemia produced no hippocampal
neuronal death in the diabetic rats (Figure 1C and D).
A single episode of moderate hypoglycemia does not
induce oxidative injury in hippocampal CA1 dendrites
To test whether a single episode of moderate hypoglycemia
induces oxidative injury at or proximal to hippocampal
dendrites, rat hippocampus was evaluated at 24 h after a
single episode of moderate hypoglycemia. Here we
found only low levels of 4HNE fluorescent signal in SR
area of hippocampus after a single episode of moderate
hypoglycemia in either the non-diabetic or the diabetic
rats (Figure 2).
R/M hypoglycemia induces significant oxidative injury in
the hippocampal stratum radiatum area
Since a single episode of moderate hypoglycemia induced
no obvious oxidative injuries in the SR, rats were exposed
to recurrent hypoglycemia for 5 consecutive days. One
day after the final episode of R/M hypoglycemia (after
five episodes of R/M hypoglycemia), brains were exam-
ined to determine if oxidative injury had occurred in
Figure 2 A single episode of moderate hypoglycemia does not
induce oxidative injury in the hippocampal CA1 dendritic area.
(A) Fluorescent images show MAP2 (green) and 4HNE (red) antibody
stained stratum radiatum (SR) of hippocampal CA1 area. The 4HNE
intensity in the dendritic area after a single episode of moderate
hypoglycemia (M-HG) is almost identical between non-diabetic
(saline treated) and diabetic rats. SP, Stratum pyramidale.
Bar = 100 μm. (B) Bar graph represents quantitated 4HNE fluorescent
intensity from the SR area of hippocampal CA1 area. Data are
mean+ s.e.m.; n= 5.
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hippocampal dendritic area. Compared with a single epi-
sode of moderate hypoglycemia, exposure to five con-
secutive episodes leads to significant oxidative injury in
the hippocampal dendrite area. 4HNE fluorescent inten-
sity was increased by 419% in the SR area of hippocam-
pus of non-diabetic rats. 4HNE fluorescence intensity
was increased by 549% in the diabetic rats over non-
diabetic rats (Figure 3).
R/M hypoglycemia induces microglial activation
We tested whether R/M hypoglycemia also induces
microglial activation in the cerebral cortex and the
hippocampus. Rats were exposed for 5 days to R/M
hypoglycemia and brains were harvested after the final
episode of R/M hypoglycemia. Compared to sham
hypoglycemia operated rats, microglia were activated in
the cerebral cortex and in the hippocampus after R/M
hypoglycemia in normoglycemic rats. The degree of
microglial activation in the hippocampus of diabetic rats
was significantly higher than in normoglycemic rats
(>194%, Figure 4).
R/M hypoglycemia worsens impairment in spatial
learning and memory in diabetic rats
We next examined whether hippocampal oxidative in-
jury observed following R/M hypoglycemia correlated
with the presence of memory deficits. Rats were sub-
jected to testing designed to evaluate spatial learning in
the Barnes maze that heavily relies on hippocampal
function. Over the 5 days of training, all groups learned
the spatial task as evidenced by a progressive reduction
in the distance traveled to reach the escape tunnel in
the Barnes maze test (F4, 264 = 95.7; P< 0.01). There
was also a significant difference in the performance
during the acquisition phase of the Barnes maze test
between groups. In general, diabetic rats traveled sig-
nificantly longer distances to reach the escape tunnel
compared to non-diabetic rats (Two-way RANOVA,
STZ effect: F1, 66 = 17.5; P< 0.01) (Figure 5A). Post-hoc
analysis suggests that diabetic rats with R/M
hypoglycemia performed significantly worse than either
diabetic sham hypoglycemic rats (P< 0.05), or non-
diabetic rats with R/M hypoglycemia (P< 0.01)
(Figure 5A).
Diabetes, but not R/M hypoglycemia, alters exploratory
behavior
To investigate whether R/M hypoglycemia induces ac-
tivity changes in either non-diabetic or diabetic animals,
rats were subjected to an open field test at 6 weeks after
the final episode of R/M hypoglycemia. All groups were
able to habituate over 3 days of testing in the novel
open field (Figure 5B to D, total path length: P< 0.01;
total active time: P< 0.0001; rearing: P< 0.01). Diabetes
had a strong effect on locomotion (Figure 5B to D, total
path length: P< 0.01; total active time: P< 0.01; rearing:
P< 0.01), while R/M hypoglycemia did not reduce loco-
motion (5B to D, total path length: P= 0.16; total active
time: P= 0.49; rearing: P= 0.40). Because the novel en-
vironment in the open field concurrently evokes both
anxiety and exploration [47,48], an increase in time
spent in the center of the open field suggests reductions
in anxiety and/or increases in exploration [47]. Diabetic
Figure 3 Repeated episodes of moderate hypoglycemia
induce a significant increase in oxidative injury in the
hippocampal CA1 dendritic area. (A) Fluorescent images show
MAP2 (green) and 4HNE (red) antibody stained stratum radiatum
(SR) of hippocampal CA1 area. The 4HNE intensity in the
dendritic area after R/M hypoglycemia (R/M HG) is substantially
increased. This 4HNE intensity increase is much higher in the
diabetic rats, which suggests oxidative injury in the dendritic area of
hippocampus is worse in the diabetic animal. SP, Stratum
pyramidalae. Bar = 100 μm. (B) Bar graph represents quantitated
4HNE fluorescent intensity from the SR area of hippocampal
CA1 area. Data are mean+ s.e.m.; n= 7, * P< 0.05.
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rats also displayed an anxiety-like behavior by reducing
exploratory activity in the center zone in the open arena
(Figure 5E and F, Z2 path length: P< 0.01; Z2 time:
P< 0.01). Diabetic rats experiencing consecutive R/M
hypoglycemia displayed an anxiety-like behavior com-
pared to their non-diabetic counterparts (post hoc: Z2
path length: P< 0.01; Z2 time: P< 0.01).
R/M hypoglycemia leads to decreased dendritic density
and reduced thickness of hippocampal CA1 at delayed
time points
To evaluate long-term effects of R/M hypoglycemia on
hippocampal dendritic structure, brains were histologi-
cally evaluated by MAP2 immunostaining 8 weeks after
R/M hypoglycemia (Figure 6A). Here we found that R/M
hypoglycemia reduced MAP2 intensity in the SR area of
hippocampal CA1. STZ-induced diabetic rats showed
significantly (31.65%) less MAP2 immunoreactivity in the
SR area of the hippocampus compared with non-diabetic
rats. R/M hypoglycemia in diabetic rats further decreases
MAP2 intensity (29.03%) than in non-diabetic rats
(10.15%) (Figure 6B). The thickness of the CA1 dendritic
area was also decreased by 3.81% in non-diabetic rats but
by 11.35% in diabetic rats, in concert with the decrease
in MAP2 intensity (Figure 6C).
Inhibition of NADPH oxidase prevents oxidative injury
and microglial activation after R/M hypoglycemia
To test whether NADPH oxidase activation contributes
to the dendritic injury seen in the stratum radiatum of
hippocampal CA1 area and microglial activation after
R/M hypoglycemia, we injected an NADPH oxidase in-
hibitor, apocynin, into the intraperitoneal space. Apocynin
treatment (15 mg/kg/day) reduced 4HNE fluorescence in-
tensity by 51.30% in diabetic rats after hypoglycemia.
Reduction of 4HNE fluorescent intensity represents that
R/M hypoglycemia-induced oxidative injury may be
caused by superoxide production through NADPH oxi-
dase activation. R/M hypoglycemia-induced microglia ac-
tivation was also reduced by 57.15% by apocynin
treatment in diabetic rats. The degree of reduction of
4HNE fluorescent intensity and microglia activation by
apocynin was similar in diabetic and non-diabetic rats
(Figure 7A and B).
Discussion
The present study demonstrates that R/M hypoglycemia
induces cognitive impairment associated with hippocam-
pal dendritic injury. We found that R/M hypoglycemia
induces oxidative injury in hippocampal dendrites and
that R/M hypoglycemia induces microglial activation in
the hippocampus and cerebral cortex. Both of these pro-
cesses were more pronounced in diabetic rats. R/M
hypoglycemia induces cognitive impairment 6 weeks
after insult in diabetic rats, but not in non-diabetic rats.
Finally; R/M hypoglycemia reduces dendritic density and
thickness of the SR and SM of hippocampal CA1 area.
In the present study we tested if R/M hypoglycemia in
diabetic rats could cause hippocampal dendritic injury
and cognitive impairment. Severe hypoglycemia (that in
which iso- EEG is present) induces neuronal death in
the cerebral cortex and hippocampus, and cognitive
Figure 4 R/M hypoglycemia increases microglial activation in
the hippocampus and in the cortex. (A) Brain sections were
harvested at one day after the last episode of moderate
hypoglycemia and immunostained with CD11b. R/M
hypoglycemia-induced microglial activation in the hippocampus and
in the cerebral cortex is apparent in both non-diabetic (Saline) and
diabetic (STZ) rats. Diabetic rats show substantially increased
microglial activation in the hippocampal CA1, hilus, and cortex
compared to non-diabetic rats. Scale bar = 100 μm. (B)
Quantification of microglial activation was performed from
hippocampal CA1 pyramidal area. Microglial activation is quantified
based on morphological change and intensity of CD11b
immunostaining. As shown in the images, microglial activation is
aggravated in diabetic rats. Data are mean+ s.e.m.; n= 5, * P< 0.05.
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impairment. However, moderate hypoglycemia produces
neuronal death that is restricted to the cerebral cortex
[34,49], It is not clear why this variation occurs.
To investigate whether differences in neuronal death
depend on a pre-existing diabetic condition before in-
sult, we rendered rats diabetic by STZ injection. The
present study showed cortical but not hippocampal
neuronal death, similar to what was seen in a previous
study [46]. Thus, the pattern of neuronal death in the
cerebral cortex or in the hippocampus in the diabetic
rats after R/M hypoglycemia is almost identical with
other studies, which used non-diabetic rats [34,35,49] .
Whether R/M hypoglycemia causes cognitive impair-
ment remains an important question. Repetitive
hypoglycemia in the developing brain causes selective
impairment of synaptic plasticity, in the absence of
Figure 5 R/M hypoglycemia induces cognitive impairment in diabetic rats. STZ induced impairment in spatial learning and memory by
increasing the path length traveled in the BM test (*: sham/saline vs. sham/STZ: P< 0.05; #: R/M-HG/saline vs. R/M-HG/STZ: P< 0.01). R/M
hypoglycemia (R/M-HG) induced spatial learning and memory impairment only in the diabetic (*: R/M-HG/STZ vs. sham/STZ: P< 0.05), but not in
non-diabetic rats (R/M-HG/saline vs. sham/saline: P= 0.65) (A). Diabetes but not R/M-HG reduced overall locomotor activity as evidenced by
reduced total distance traveled (B), total active time (C) and vertical activity in rearing (D). Similarly, diabetes but not R/M-HG altered exploratory
behavior by reducing activity in the center zone (Z2) of an open field (E, F) (D1, D2, and D3=Day1, Day2, and Day3). Post-hoc analysis suggests
that there are significant differences between R/M-HG/saline and R/M-HG/STZ in total distance (labeled as & in B), total active time (labeled
as * in C), rearing events (labeled as & in D), Z2 distance (labeled as % in E) and Z2 total time (labeled as * in F). There were also significant
differences between sham/saline and sham/STZ in total distance (# in B), rearing events (& in D), Z2 distance (# in E) and Z2 total time (* in F).
*: P< 0.05, #: P< 0.01, %: P< 0.005, and &: P< 0.001.
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hippocampal neuronal death, suggesting that impaired
synaptic plasticity in the hippocampus caused by repeti-
tive hypoglycemia could underlie memory and cognitive
deficits observed in diabetic children [35]. In the present
study, we tested the hypothesis that R/M hypoglycemia
may cause oxidative injury in hippocampal dendrites
[16,45]. To do this, we subjected young diabetic and
healthy rats to R/M hypoglycemia and evaluated by
immunostaining for 4HNE, an α,β-unsaturated hydro-
xyalkenal produced by lipid peroxidation in cells. 4HNE
immunoreactivity in the hippocampal dendritic area was
substantially increased after sequential hypoglycemic
events, and was higher in diabetic rats compared to
non-diabetic rats. Next we asked if oxidative injury could
be induced after only a single episode of moderate
hypoglycemia. Neither diabetic nor non-diabetic rats
showed oxidative injury after only one episode, suggest-
ing that repetitive moderate hypoglycemia events are
required to induce oxidative injury in the hippocampal
dendritic area. Our results also confirm previous find-
ings that hypoglycemia induces lipid peroxidation in
discrete regions of the forebrain [34,50].
Previously, McNay and Sherwin published the intriguing
result that R/M hypoglycemia actually led to cognitive im-
provement in rats [51]. In the study, they performed a
spatial working memory test shortly (20 min) after R/M
hypoglycemia (3 h daily for 3 days). This improvement
was equal in diabetic and non-diabetic rats, in contrast to
the present study. However, a major difference between
these studies is that behavioral testing in the present study
was conducted 6 weeks after R/M hypoglycemia. Another
study showed that R/M hypoglycemia prevented subse-
quent severe hypoglycemia-induced neuronal death and
cognitive impairment [38]. This acute preconditioning ef-
fect is not relevant to the chronic functional impairment
described here.
Microglial activation is also induced by severe
hypoglycemia, and can contribute to neuronal injury
[52], by releasing several neurotoxic substances, includ-
ing superoxide, nitric oxide, and metalloproteinase
[43,53-56] In the present study, we found that R/M
hypoglycemia also induced microglial activation in the
hippocampus, as seen in severe hypoglycemia [52], and
diabetic rats showed higher microglial activation after
R/M hypoglycemia. Thus, this confirms that the inflam-
matory response was also induced after R/M
hypoglycemia, but whether this inflammatory response
contributes to the oxidative stress or later cognitive im-
pairment is not established.
Debate continues over the role of hypoglycemia and/
or hyperglycemia in producing cognitive impairment in
type 1 diabetes. In the present study, non-diabetic rats
showed no obvious cognitive impairments after R/M
hypoglycemia, but diabetic rats showed statistically sig-
nificant cognitive impairment. Why was cognitive im-
pairment only seen in the diabetic rats after R/M
hypoglycemia? The present study does not provide a
clear answer for this; however, we can speculate that less
severe oxidative injury in the non-diabetic rats or
impaired recovery in the diabetic rats influenced this. In
support of these possibilities, we found that R/M
hypoglycemia reduced MAP2 intensity and thickness in
the stratum radiatum area of hippocampal CA1, more so
in diabetic than in non-diabetic rats. Synaptic density in
the hippocampus plays a crucial role in memory [57].
For example, synaptic density in the CA1 stratum radia-
tum is regulated by estrogen, leading to modulation of
long-term depression (LTD) and long-term potentiation
Figure 6 R/M hypoglycemia decreases dendrite density and
thickness of stratum radiatum (SR) and stratum moleculare
(SM) layer of hippocampal CA1 8 weeks after injury. (A)
Fluorescent images show MAP2 (green) antibody stained stratum
radiatum (SR) stratum moleculare (SM) of hippocampal CA1 area
8 weeks after R/M hypoglycemia. The MAP2 intensity in the
dendritic area after R/M hypoglycemia (R/M HG) is substantially
decreased. This MAP2 intensity decrease is more obvious in the
diabetic rats, which suggests R/M hypoglycemia-induced dendrite
loss in the SR and SM of hippocampus is worse in the diabetic
animal. SP, Stratum Pyramidalae. Bar = 200 μm. (B) Bar graph
represents quantitated MAP2 fluorescent intensity from the SR area
of hippocampal CA1 area. Square in (A) shows evaluated area of
MAP2 fluorescent intensity. (C) Bar graph represents thickness of
SR + SM area of hippocampal CA1 area. Data are mean+ s.e.m.; n= 7,
* P< 0.05.
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(LTP) [58]. Evidence suggests that diabetes, stress, and
aging negatively affect synaptic plasticity in brain regions
including the hippocampus and the cortex, which can
lead to persistent inhibition of LTP and facilitation of
LTD and in turn might lead to activity-dependent synapse
weakening and contribute to cognitive impairments [59].
We found that R/M hypoglycemia-induced oxidative
damage in hippocampal dendrites and microglial activa-
tion was reduced by the NADPH oxidase inhibitor, apocy-
nin, suggesting a mechanism by which R/M hypoglycemia
may promote oxidative stress in the hippocampus during
reperfusion. Glucose reperfusion-induced dendritic in-
jury results in part from the activation by superoxide
produced through NADPH oxidase. NADPH oxidase
generates superoxide through a process that requires glu-
cose as a substrate for NADPH production, such that
glucose availability can be the rate-limiting factor in
superoxide production by this process [42,60,61].
Extrapolating these results to clinical settings has some
limitations. The experimental paradigm of hypoglycemia
for 5 consecutive days is intended to model recurrent
hypoglycemia, but the effects over time of widely spaced
hypoglycemic intervals may differ from the tightly
spaced recurrences used here. Similarly, the diabetic rats
were subjected to much greater variations in glucose
than would typically occur in clinical settings. They also
Figure 7 R/M hypoglycemia-induced dendritic oxidative injury and microglial activation was reduced by the NADPH oxidase inhibitor,
apocynin. (A) Fluorescent images show MAP2 (green) and 4HNE (red) antibody stained stratum radiatum (SR) of hippocampal CA1 area. The
4HNE intensity in the dendritic area after R/M hypoglycemia (R/M HG) is substantially increased in diabetic and non-diabetic rats. The NADPH
oxidase inhibitor, apocynin (Apo), reduced 4HNE intensity is much higher in the diabetic and in the non-diabetic rats, which suggests R/M
hypoglycemia-induced oxidative injury in the dendritic area of hippocampus is mediated by NADPH oxides activation. SP, Stratum pyramidalae.
Bar = 100 μm. (B) Bar graph represents quantitated 4HNE fluorescent intensity from the SR area of hippocampal CA1 area. Data are mean+ s.e.m.;
n= 7, * P< 0.05. (C) Brain sections were harvested at 1 day after the last episode of moderate hypoglycemia and immunostained with CD11b.
R/M hypoglycemia-induced microglial activation in the hippocampus is apparent in both non-diabetic and diabetic rats. Apocynin (Apo)
treatment reduced microglia activation in the diabetic or in the non-diabetic rats. Scale bar = 100 μm. (D) Quantification of microglial activation
was performed from hippocampal CA1 pyramidal area. Microglial activation is quantified based on morphological change and intensity of
CD11b immunostaining. Data are mean+ s.e.m.; n=5, * P< 0.05.
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were subjected to much greater changes in plasma glu-
cose than the non-diabetic rats, a factor which may have
contributed to the differences observed between the dia-
betic and non-diabetic rats. Last, rodent brains may dif-
fer from human brains in their responses to R/M
hypoglycemia. Further research, particularly from the
translational and clinical perspective is needed to resolve
these questions.
Additional files
Additional file 1: Figure S1. Experimental protocol for R/M
hypoglycemia or A/S hypoglycemia in the diabetic rats. Type 1 diabetes
rats were induced by 2 consecutive days of intraperitoneal streptozotocin
(50 mg/kg) injection. One week after STZ injection, diabetic rats were
subjected to either moderate hypoglycemia for 5 consecutive days (A) or
severe hypoglycemia once (B). For moderate hypoglycemia, rats were
unanesthetized during entire experiment. One group of rats was
sacrificed at 24 h after the last moderate hypoglycemia episode for
histological evaluation for neuron death (FJB), oxidative damage (4HNE),
and microglial activation (CD11b). The other group of rats was subjected
to cognitive function evaluation with the Barnes maze behavioral test
6 weeks after R/M hypoglycemia and then sacrificed for MAP2 staining.
For severe hypoglycemia, rats were anesthetized by isoflurane during
entire hypoglycemia surgery. Rats were sacrificed 1 week after
hypoglycemia for assessment of neuron death (FJB), oxidative damage
(4HNE), and microglial activation (CD11b).
Additional file 2: Figure S2. EEG and blood glucose changes during
hypoglycemia in diabetic rats. Insulin injection increases amplitude and
reduces frequency of cortical EEG. Iso-EEG (flat line, e) was induced 4 h
after 30 U/kg insulin injections. Initial fasting blood glucose concentration
from diabetic rats in this experiment was above 15 mM. This blood
glucose concentration was quickly decreased immediately after insulin
injection. During the iso-EEG, blood glucose concentration was below
0.5 mM. After glucose reperfusion (G/R), blood glucose concentration was
increased above 9 mM.
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